NME

Notis-McConarty Edward Portfolio holdings

AUM $205M
This Quarter Return
+6.54%
1 Year Return
+14.8%
3 Year Return
+72.99%
5 Year Return
+119.96%
10 Year Return
+295.3%
AUM
$270M
AUM Growth
+$270M
Cap. Flow
-$3.1M
Cap. Flow %
-1.15%
Top 10 Hldgs %
35.07%
Holding
98
New
3
Increased
17
Reduced
48
Closed

Sector Composition

1 Healthcare 23.85%
2 Technology 23.37%
3 Industrials 12.37%
4 Consumer Discretionary 7.83%
5 Consumer Staples 7.48%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
UL icon
26
Unilever
UL
$156B
$3.37M 1.25%
57,596
+3,470
+6% +$203K
NVDA icon
27
NVIDIA
NVDA
$4.15T
$3.35M 1.24%
4,190
-436
-9% -$349K
PEP icon
28
PepsiCo
PEP
$206B
$3.31M 1.23%
22,354
LOW icon
29
Lowe's Companies
LOW
$145B
$3.17M 1.17%
16,350
-1,250
-7% -$242K
XYL icon
30
Xylem
XYL
$34.1B
$3.02M 1.12%
25,160
-35
-0.1% -$4.2K
XOM icon
31
Exxon Mobil
XOM
$488B
$2.94M 1.09%
46,664
-1,700
-4% -$107K
BDX icon
32
Becton Dickinson
BDX
$54.2B
$2.94M 1.09%
12,075
+338
+3% +$82.2K
HON icon
33
Honeywell
HON
$138B
$2.79M 1.03%
12,695
+755
+6% +$166K
TJX icon
34
TJX Companies
TJX
$154B
$2.74M 1.02%
40,704
+4,445
+12% +$300K
NKE icon
35
Nike
NKE
$110B
$2.42M 0.9%
15,670
+1,752
+13% +$271K
JPM icon
36
JPMorgan Chase
JPM
$821B
$2.42M 0.9%
15,558
-1,375
-8% -$214K
ACN icon
37
Accenture
ACN
$159B
$2.41M 0.89%
8,189
-250
-3% -$73.7K
SYK icon
38
Stryker
SYK
$149B
$2.4M 0.89%
9,250
-5
-0.1% -$1.3K
UNH icon
39
UnitedHealth
UNH
$280B
$2.28M 0.84%
5,686
+204
+4% +$81.7K
AMGN icon
40
Amgen
AMGN
$154B
$2.16M 0.8%
8,853
-912
-9% -$222K
UNP icon
41
Union Pacific
UNP
$131B
$2.08M 0.77%
9,440
ECL icon
42
Ecolab
ECL
$78B
$1.78M 0.66%
8,650
-750
-8% -$155K
MMM icon
43
3M
MMM
$82.1B
$1.7M 0.63%
8,565
-5,554
-39% -$1.1M
EMR icon
44
Emerson Electric
EMR
$73.6B
$1.62M 0.6%
16,835
-275
-2% -$26.5K
ADBE icon
45
Adobe
ADBE
$146B
$1.61M 0.6%
2,750
CHD icon
46
Church & Dwight Co
CHD
$22.7B
$1.61M 0.6%
18,875
CVX icon
47
Chevron
CVX
$325B
$1.52M 0.56%
14,562
+315
+2% +$33K
ITW icon
48
Illinois Tool Works
ITW
$76.5B
$1.48M 0.55%
6,610
BMY icon
49
Bristol-Myers Squibb
BMY
$96.4B
$1.46M 0.54%
21,850
MRK icon
50
Merck
MRK
$213B
$1.45M 0.54%
18,685